A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.
Saved in:
| Title: | A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers. |
|---|---|
| Authors: | Wohlford GF; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Buckley LF; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Kadariya D; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Park T; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Chiabrando JG; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Carbone S; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Mihalick V; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Halquist MS; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Pearcy A; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America., Austin D; Serpin Pharma LLC, Manassas, Virginia, United States of America., Gelber C; Serpin Pharma LLC, Manassas, Virginia, United States of America., Abbate A; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America., Van Tassell B; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America. |
| Source: | PloS one [PLoS One] 2021 May 06; Vol. 16 (5), pp. e0247357. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021). |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33956804 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wohlford+GF%22">Wohlford GF</searchLink>; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Buckley+LF%22">Buckley LF</searchLink>; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Kadariya+D%22">Kadariya D</searchLink>; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Park+T%22">Park T</searchLink>; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Chiabrando+JG%22">Chiabrando JG</searchLink>; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Carbone+S%22">Carbone S</searchLink>; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Mihalick+V%22">Mihalick V</searchLink>; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Halquist+MS%22">Halquist MS</searchLink>; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Pearcy+A%22">Pearcy A</searchLink>; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Austin+D%22">Austin D</searchLink>; Serpin Pharma LLC, Manassas, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Gelber+C%22">Gelber C</searchLink>; Serpin Pharma LLC, Manassas, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Abbate+A%22">Abbate A</searchLink>; Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.<br /><searchLink fieldCode="AU" term="%22Van+Tassell+B%22">Van Tassell B</searchLink>; Virginia Commonwealth University School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2021 May 06; Vol. 16 (5), pp. e0247357. <i>Date of Electronic Publication: </i>2021 May 06 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33956804 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0247357 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0247357 Titles: – TitleFull: A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wohlford GF – PersonEntity: Name: NameFull: Buckley LF – PersonEntity: Name: NameFull: Kadariya D – PersonEntity: Name: NameFull: Park T – PersonEntity: Name: NameFull: Chiabrando JG – PersonEntity: Name: NameFull: Carbone S – PersonEntity: Name: NameFull: Mihalick V – PersonEntity: Name: NameFull: Halquist MS – PersonEntity: Name: NameFull: Pearcy A – PersonEntity: Name: NameFull: Austin D – PersonEntity: Name: NameFull: Gelber C – PersonEntity: Name: NameFull: Abbate A – PersonEntity: Name: NameFull: Van Tassell B IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 05 Text: 2021 May 06 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 16 – Type: issue Value: 5 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |